BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35563197)

  • 1. Bacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis.
    Walker AC; Bhargava R; Dove AS; Brust AS; Owji AA; Czyż DM
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization of the Caenorhabditis elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate.
    Walker AC; Bhargava R; Vaziriyan-Sani AS; Pourciau C; Donahue ET; Dove AS; Gebhardt MJ; Ellward GL; Romeo T; Czyż DM
    PLoS Pathog; 2021 May; 17(5):e1009510. PubMed ID: 33956916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases.
    Nussbaum-Krammer CI; Morimoto RI
    Dis Model Mech; 2014 Jan; 7(1):31-9. PubMed ID: 24396152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular protein homeostasis in neurodegenerative diseases.
    Wilson MR; Satapathy S; Vendruscolo M
    Nat Rev Neurol; 2023 Apr; 19(4):235-245. PubMed ID: 36828943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Protein Aggregates: Formation, Biological Effects, and Ways of Elimination.
    Wen JH; He XH; Feng ZS; Li DY; Tang JX; Liu HF
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.
    Brehme M; Voisine C; Rolland T; Wachi S; Soper JH; Zhu Y; Orton K; Villella A; Garza D; Vidal M; Ge H; Morimoto RI
    Cell Rep; 2014 Nov; 9(3):1135-50. PubMed ID: 25437566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans.
    Garcia Manriquez BA; Papapanagiotou JA; Strysick CA; Green EH; Kikis EA
    PLoS One; 2023; 18(2):e0275137. PubMed ID: 36821635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases.
    Walker AC; Bhargava R; Bucher M; Brust AS; Czy DM
    bioRxiv; 2023 Oct; ():. PubMed ID: 37961318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose delays age-dependent proteotoxicity.
    Tauffenberger A; Vaccaro A; Aulas A; Vande Velde C; Parker JA
    Aging Cell; 2012 Oct; 11(5):856-66. PubMed ID: 22734670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of protein homeostasis and aggregation.
    Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
    J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental factors modulating protein conformations and their role in protein aggregation diseases.
    Devi S; Chaturvedi M; Fatima S; Priya S
    Toxicology; 2022 Jan; 465():153049. PubMed ID: 34818560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic screening strategy identifies novel regulators of the proteostasis network.
    Silva MC; Fox S; Beam M; Thakkar H; Amaral MD; Morimoto RI
    PLoS Genet; 2011 Dec; 7(12):e1002438. PubMed ID: 22242008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical kinetics for drug discovery to combat protein aggregation diseases.
    Arosio P; Vendruscolo M; Dobson CM; Knowles TP
    Trends Pharmacol Sci; 2014 Mar; 35(3):127-35. PubMed ID: 24560688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oh my gut! Is the microbial origin of neurodegenerative diseases real?
    Walker A; Czyz DM
    Infect Immun; 2023 Oct; 91(10):e0043722. PubMed ID: 37750713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluc-EGFP reporter mice reveal differential alterations of neuronal proteostasis in aging and disease.
    Blumenstock S; Schulz-Trieglaff EK; Voelkl K; Bolender AL; Lapios P; Lindner J; Hipp MS; Hartl FU; Klein R; Dudanova I
    EMBO J; 2021 Oct; 40(19):e107260. PubMed ID: 34410010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events.
    Jackrel ME; DeSantis ME; Martinez BA; Castellano LM; Stewart RM; Caldwell KA; Caldwell GA; Shorter J
    Cell; 2014 Jan; 156(1-2):170-82. PubMed ID: 24439375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial sequestration of misfolded proteins in neurodegenerative diseases.
    Rolli S; Sontag EM
    Biochem Soc Trans; 2022 Apr; 50(2):759-771. PubMed ID: 35311889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.